Danial E. Baker, Pharm.D., FASHP, FASCP

Education
Doctor of Pharmacy, University of Minnesota
Bachelor of Pharmacy, Washington State University

Fellowships
Fellow of the American Society of Consultant Pharmacists (FASCP)
Fellow of the American Society of Hospital Pharmacists (FASHP)

Teaching
Dr. Danial Baker's teaching activities include gastrointestinal disorders, drug information, and evidence based medicine. He has been the director of WSU’s Drug Information Center since 1983 and is a professor of pharmacotherapy.

Research
Expertise: medications, drug information

Dr. Baker is an assistant editor for Hospital Pharmacy. He is an editorial board member for Facts & Comparisons, The Formulary Monograph Service and Hospital Pharmacy. He is on the advisory board for Accredo Therapeutics’ Specialty Drug Advisory Board. He is a consultant to the Food and Drug Administration’s Arthritis Advisory Committee, a member of the United States Pharmacopeia Committee of Experts on Healthcare Quality and its Medicare Model Guidelines subcommittee, Model Guidelines for All Marketed Products Expert Panel, and Safety Subcommittee. He is a peer reviewer for the American Pharmacy Association, American Society of Health-System Pharmacy, The Annals of Pharmacotherapy, Pharmacotherapy, Hospital Formulary, Hospital Pharmacy, Journal of Managed Care Pharmacy, The Medical Letter, BMC Health Services Research, Journal of Diabetes and Its Complications, Biochemistry and Biophysics Reports, Current Medical Research & Opinion, and Expert Review of Clinical Immunology.

He was a member of the Pharmacy & Therapeutics Committee for Medco Health Solutions, LLC for 17 years, Washington State’s Drug Review Advisory Committee for 3 years, Washington State’s Drug Utilization and Education Council for 4 years, IHC Health Plans for 2 years, and Whatcom Medical Bureau’s Pharmacy & Therapeutics Committee for 3 years, and the United States Pharmacopeia. He has been a member of advisory boards or panels for Searle Pharmaceuticals, Upjohn, Astra, Syntex, Wyeth, Novartis, and Pharmacia.

Dr. Baker is actively involved in research and publications. He has published over 2,800 papers in various pharmacy and medical journals, and drug information systems. His interests include drug information, managed care, evidence-based medicine, drug formularies, and outdoor emergency medical care.

Additional Information
Baker received numerous awards and honors including the Smith, Kline & French Laboratories Award for Superior Achievement in Clinical Pharmacy, WSPA Pharmacist of the Year, WSU Faculty Excellence Award, Who's Who in American Education, Who's Who in the World, and numerous awards and recognitions from the National Ski Patrol. He is a fellow of the American Society of Consultant Pharmacists and the American Society of Hospital Pharmacists.

Recognition:
Who’s Who in America, 60th Edition, 2016

National Ski Patrol's Distinguished Service Award, 2013

Selected Publications
Baker DE, Wu J. Drug Evaluation – Patiromer (Veltassa): Updated Evaluation. In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. January 2016.

Baker DE. Drug Evaluation – Cariprazine (Vraylar): Updated Evaluation. In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. January 2016.

Bindler RJ, Baker DE. Drug Evaluation – Coagulation factor VIII/antihemophilic factor (recombinant)/simoctocog alfa (Nuwiq). In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. January 2016.

Kim AP, Baker DE. Drug Evaluation – Idarucizumab (Praxbind): Updated Evaluation. In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. January 2016.

Levien TL, Baker DE. Drug Evaluation – Trifluridine/tipiracil (Lonsurf). In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. January 2016.

Baker DE. Drug Utilization Evaluation – Idarucizumab (Praxbind). In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. January 2016.

Kim AP, Baker DE. Drug Evaluation – Cobimetinib (Cotellic): Updated Evaluation. In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. February 2016.

Baker DE. Drug Evaluation – Indacaterol/glycopyrrolate (Utibro Neohaler): Updated Evaluation. In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. February 2016.

Levien TL, Baker DE. Drug Evaluation – Glycopyrrolate (Seebri Neohaler). In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. February 2016.

Bindler RJ, Baker DE. Drug Evaluation – Coagulation Factor X (Coagadex). In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. February 2016.

Bindler RJ, Baker DE. Drug Evaluation – Mepolizumab (Nucala). In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. February 2016.

Baker DE. Drug Utilization Evaluation – Mepolizumab (Nucala). In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. February 2016.

Levien TL, Baker DE. Drug Evaluation – Trabectedin (Yondelis). In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. March 2016.

Baker DE, Leonard J. Drug Evaluation – Talimogene laherparepvec (Imlygic). In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. March 2016.

Bindler RJ, Baker DE. Drug Evaluation – Asfotase alfa (Strensiq). In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. March 2016.

Knotts AM, Levien TL, Baker DE. Drug Evaluation – Necitumumab (Portrazza). In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. March 2016.

Knotts AM, Baker DE, Levien TL. Drug Evaluation – Osimertinib (Tagrisso). In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. March 2016.

Baker DE. Drug Utilization Evaluation – Patiromer (Veltassa). In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. March 2016.

Mbogu U, Bindler RJ, Baker DE. Drug Evaluation – Uridine triacetate (Vistogard). In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. April 2016.

Bindler RJ, Baker DE. Drug Evaluation – von Willebrand factor (Recombinant) (Vonvendi). In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. April 2016.

Kim AP, Baker DE. Drug Evaluation – Elotuzumab (Empliciti). In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. April 2016.

Kim AP, Baker DE. Drug Evaluation – Daratumumab (Darzalex). In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. April 2016.

Kim AP, Baker DE. Drug Evaluation – Ixazomib (Ninlaro). In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. April 2016.

Baker DE. Drug Utilization Evaluation – Lesinurad (Zurampic). In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. April 2016.

Bindler RJ, Baker DE. Drug Evaluation – Selelipase alfa (Kanuma). In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. May 2016.

Ali Z, Baker DE. Drug Evaluation – Selexipag (Uptravi). In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. May 2016.

Kim AP, Baker DE. Drug Evaluation – Lesinuard (Zurampic). In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. May 2016.

Levien TL, Baker DE. Drug Evaluation – Sugammadex (Bridion). In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. May 2016.

Bindler RJ, Baker DE. Drug Evaluation – Alectinib (Alecensa). In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. May 2016.

Baker DE. Drug Utilization Evaluation – Sugammadex (Bridion). In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. May 2016.

Baker DE. Drug Evaluation – Ixekizumab (Taltz). In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. June 2016.

Baker DE. Drug Evaluation – Brivaracetam (Briviact). In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. June 2016.

Baker DE, Levien TL. Drug Evaluation – Reslizumab (Cinqair): Updated Evaluation. In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. June 2016.

Kim AP, Baker DE. Drug Evaluation – Elbasvir/grazoprevir (Zepatier). In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. June 2016.

Bindler RJ, Baker DE. Drug Evaluation – Sofosbuvir/velpatasvir: Preliminary Evaluation. In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. June 2016.

Baker DE. Drug Utilization Evaluation – Reslizumab (Cinqair). In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. June 2016.

Baker DE, Demaris K. Drug Evaluation – Defibrotide (Defitelio): Upated Evaluation. In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. July 2016.

Bindler RJ, Baker DE. Drug Evaluation – Venetoclax (Venclexia). In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. July 2016.

Kim AP, Baker DE. Drug Evaluation – Atezolizumab: Preliminary Evaluation. In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. July 2016.

Baker DE, Knotts AM, Levien TL. Drug Evaluation – Lifitegrast: Preliminary Evaluation. In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. July 2016.

Ali ZK, Baker DE. Drug Evaluation – Pimavanserin (Nuplazid): Updated Evaluation. In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. July 2016.

Baker DE. Drug Utilization Evaluation – Pimavanserin (Nuplazid). In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. July 2016.

Kim AP, Baker DE. Drug Evaluation – Daclizumab (Zinbryta): Updated Evaluation. In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. August 2016.

Baker DE. Drug Evaluation – Bezlotoxumab (Zinplava): Preliminary Evaluation. In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. August 2016.

Bindler RJ, Baker DE. Drug Evaluation – Andexanet alfa: Preliminary Evaluation. In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. August 2016.

Kim AP, Baker DE. Drug Evaluation – Obeticholic acid (Ocaliva). In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. August 2016.

Kim AP, Baker DE. Drug Evaluation – Atezolizumab (Tecentriq): Updated Evaluation. In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. August 2016.

Baker DE. Drug Utilization Evaluation – Brivaracetam (Briviact). In: Cada DJ, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM). St. Louis, MO: Wolters Kluwer Health. August 2016.

Levien TL, Baker DE. Fenatnyl iontophoretic transdermal system. Hospital Pharmacy 2016;51(1):71-82.

Baker DE. Approvals, Submission, and Important Labeling Changes for U.S. Marketed Pharmaceuticals. Hospital Pharmacy 2016;51(1):86-88.

Bindler RJ, Baker DE. Rolapitant. Hospital Pharmacy. 2016;51(2):165-178.

Baker DE. Approvals, Submission, and Important Labeling Changes for U.S. Marketed Pharmaceuticals. Hospital Pharmacy 2016;51(2):179-181.

Kim AP, Baker DE. Idarucizumab. Hospital Pharmacy 2016;51(3):256-262.

Baker DE. Zika virus & the media. Hospital Pharmacy 2016;51(4):275-276.

Dang J, Baker DE. Patiromer. Hospital Pharmacy 2016;51(4):328-336.

Bindler RJ, Baker DE. Mepolizumab. Hospital Pharmacy 2016;51(5):405-414.

updated 07/01/2016     Back to top
photo of Daniel Baker

Associate Dean
External Professional & Continuing Education

Professor
Pharmacotherapy Department

Director
Drug Information Center

Danial.Baker@wsu.edu
509-358-7660

Office: HSB 210 P
P.O. Box 1495
Washington State University
Spokane, WA 99210-1495